TNDM EBITDA Growth
Tandem Diabetes Care Inc · EBITDA Growth
TNDM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported80.40%period ending
TNDM TTM EBITDA YoY % (-67.26% → 80.40%)
Year-over-year change
High-resolution chart · PNG
TNDM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 80.4026% | |
| 52.2856% | |
| -155.5398% | |
| -79.6958% | |
| -67.5463% | |
| -35.8077% | |
| 65.1467% | |
| 45.0023% | |
| 47.3855% | |
| 38.7316% | |
| -165.9128% | |
| -290.4258% | |
| -3,448.787% | |
| -889.9581% | |
| -313.7356% | |
| -206.4915% | |
| -81.1247% | |
| 3,552.4096% | |
| 356.7334% | |
| 228.4368% | |
| 194.1307% | |
| 93.297% | |
| 27.448% | |
| -63.2437% | |
| 33.4597% | |
| 90.6326% | |
| 83.5175% | |
| 82.727% | |
| 49.4799% | |
| -67.2307% | |
| -104.8117% | |
| -100.2039% | |
| -32.5519% | |
| 14.9631% | |
| 24.3795% | |
| 14.6288% | |
| -24.4479% | |
| -18.3163% | |
| -13.016% | |
| -0.4007% | |
| 13.6115% | |
| 10.9595% | |
| 9.9627% | |
| 2.173% | |
| -8.4501% | |
| -15.5598% | |
| -41.4825% | |
| -74.4895% | |
| -67.2625% |